Oncology Corporate Profile
Light Sciences (now LSO) was founded in 1994 to find and produce a commercially viable light-activated drug product to treat patients with solid tumor cancers.
|Brand / Product||Class||Area of Study||Phase||Partnership|
|Aptocine®||light activated drug treatment||1st line metastatic Colorectal cancer||III|
|Aptocine®||light activated drug treatment||Hepatocellular carcinoma (HCC)||III|
|Aptocine®||light activated drug treatment||Glioma||II|
View additional information on product candidates here »
11/2/2016 11:12 am
(BMS) Nov 2, 2016 - Interim data evaluating the efficacy of lirilumab, an anti-KIR antibody, in combination with Opdivo (nivolumab), a PD-1 inhibitor, will be presented in a late-breaking oral session; late-breaking data from CheckMate -032 studying Opdivo plus Yervoy (ipilimumab) in metastatic urothelial carcinoma will also be presented.
10/20/2016 11:20 am
(ACCCBuzz) Oct 20, 2016 - We’re in St. Louis for the ACCC 33rd National Oncology Conference this week. Events got underway on Wednesday, October 19, with dynamic pre-conference sessions focused on some of the most challenging and rapidly evolving areas in cancer care delivery. Read on for highlights from the Oncology Pharmacy Education Network (OPEN) pre-conference.
10/19/2016 11:43 am
(Politico/Politico Pulse) Oct 19, 2016 - Tonight's debate could be another prime-time moment for health care.
10/19/2016 11:41 am
(PharmaTimes [UK]) Oct 19, 2016 - The European Medicines Agency has now issued a green light for Shire's pancreatic therapy Onivyde, following its US approval in July this year.
10/12/2016 11:34 am
(Penn Medicine) Oct 6, 2016 - Newly published research from Penn Medicine infection control specialists found that ultraviolet (UV) robots helped reduce the rates of transmission of the common bacterial infection known as Clostridium difficile (C. diff) among cancer inpatients – mostly blood cancer patients, a group more vulnerable to hospital-acquired infections – by 25 percent.
10/12/2016 11:32 am
(ASCO in Action) Oct 11, 2016 - The October print issue of the Journal of Oncology Practice (JOP) is a Special Series on ASCO’s 2016 Quality Care Symposium (QCS). The issue features research and highlights from the meeting that brought together top leaders in the field to share strategies and methods for measuring and improving the quality and safety of cancer care.
10/11/2016 12:14 pm
(PharmiWeb.com) Oct 11, 2016 - Astellas Oncology announced the three winners of the inaugural C3 Prize – a global challenge designed to acknowledge non-medicine innovations to improve the cancer care experience for patients, caregivers and their loved ones – during the European Society of Medical Oncology (ESMO) Annual Congress in Copenhagen, Denmark Friday, October 7.
10/7/2016 11:00 am
(Yahoo! Finance) Oct 7, 2016 - Seattle Genetics, Inc. and Agensys, an affiliate of Astellas, today presented updated clinical data for enfortumab vedotin (ASG-22ME) and ASG-15ME at the European Society for Medical Oncology (ESMO) Congress being held October 7-11, 2016 in Copenhagen, Denmark.
10/5/2016 11:08 am
(Lilly) Oct 5, 2016 - Eli Lilly and Company will present data from several studies which further reinforce the advancement of its diverse clinical cancer portfolio during the European Society of Medical Oncology's (ESMO) 2016 Congress in Copenhagen, October 7-11.
9/29/2016 12:28 pm
(UN News Centre) Sept 28, 2016 - A revamped global database launched today by the United Nations atomic agency highlights startling disparities across the world when it comes to access to treatment and care for cancer.
9/19/2016 11:41 am
(ASCO in Action) Sept 16, 2016 - On September 16, ASCO released its most recent video about the CancerLinQ™ platform, the Society’s big data initiative to rapidly improve the quality of care for people with cancer.
9/9/2016 10:49 am
(ASCO/2016 Palliative Care in Oncology Symposium) Sept 8, 2016 - Seven studies investigating key issues in palliative care will be presented at the 2016 Palliative Care in Oncology Symposium, taking place September 9-10, at the San Francisco Marriott Marquis.
9/8/2016 11:26 am
(ASCO in Action) Sept 6, 2016 - Two studies on Patient Reported Outcome (PRO) measures from ASCO's 2016 Quality Care Symposium (QCS) are a part of an upcoming Journal of Oncology Practice QCS Specials Series.
8/26/2016 11:07 am
(MIT News) Aug 25, 2016 - New technique offers precise manipulation of when and where genes are targeted.
8/18/2016 11:26 am
(ASCO) Aug 17, 2016 - Co-sponsors of the 2016 Palliative Care in Oncology Symposium announced today four abstracts that will be highlighted for media.
8/18/2016 11:24 am
(Targeted Oncology) Aug 17, 2016 - Atezolizumab (Tecentriq) proves to be non-toxic and shows major survival advantage in patients with metastatic urothelial bladder cancer, according to David Nanus, MD.
8/18/2016 10:55 am
(Moffitt) Aug 18, 2016 - Lung cancer is the leading cause of cancer death for men and women. It is also one of the most complex cancers, both at the molecular level and through its clinical behavior. Screening is paramount as it helps physicians diagnose and treat the disease in its earliest stages.
8/3/2016 10:52 am
(PMLiVE [UK]) Aug 1, 2016 - The National Institute for Health and Care Excellence (NICE) has recommended Baxalta's Oncaspar (pegaspargase), a treatment for a rare form of leukaemia, in final draft guidance.
7/25/2016 11:00 am
(MIT News) July 25, 2016 - In a paper published today in the journal Nature Materials, researchers at MIT describe an adhesive patch that can stick to the colorectal tumor site, either before or after surgery, to deliver a triple-combination of drug, gene, and photo (light-based) therapy.
7/12/2016 10:15 am
(ASGE) July 11, 2016 - A look back at more than half a million patient records has established that patients with pancreatic cysts have a significantly higher overall risk of pancreatic cancer compared to those without such cysts, according to a study in the July issue of GIE: Gastrointestinal Endoscopy, the journal of the American Society for Gastrointestinal Endoscopy (ASGE).
7/6/2016 12:09 pm
(MIT News) July 5, 2016 - Researchers identify genes that mutate in endometrial cancer, create a family tree describing the evolutionary history of the disease.
6/13/2016 12:00 pm
(The Business Journals) June 11, 2016 - Phase 1 clinical data featured in press program and oral presentation demonstrate 76 percent objective response rate, including a 41 percent complete remission rate, in newly diagnosed AML patients treated with 33A combination therapy; data support recently initiated phase 3 CASCADE study evaluating 33A in combination with hypomethylating agents in AML patients.
6/10/2016 12:00 pm
(Novartis) June 10, 2016 - Novartis today announced data from the largest study of its kind confirming the long-term safety profile of Revolade (eltrombopag) in adults with chronic immune (idiopathic) thrombocytopenia (ITP), with data for up to 6 years in some patients (median exposure was 2.4 years).
6/8/2016 11:41 am
(4-traders) June 8, 2016 - Results from ZUMA-1 Phase 1 study of KTE-C19 in patients with chemorefractory diffuse large B-cell lymphoma (DLBCL); SCHOLAR-1, first meta-analysis of patient-level outcomes in chemorefractory DLBCL, an understudied patient population; results from study of anti-CD19 CAR T cells in advanced lymphoma patients, conducted in partnership with the National Cancer Institute.
6/7/2016 02:24 pm
(Onconova Therapeutics) June 6, 2016 - Onconova Therapeutics, Inc., a Phase 3 clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced the presentation of data relating to the mechanistic rationale for combining rigosertib with azacitidine at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting being held June 3-7 in Chicago, Illinois.
6/8/2012 11:01 am
(MIT) June 4, 2012 - Using a technique known as “nucleic acid origami,” chemical engineers have built tiny particles made out of DNA and RNA that can deliver snippets of RNA directly to tumors, turning off genes expressed in cancer cells.
6/7/2012 11:04 am
(Reuters) June 7, 2012 - California voters narrowly rejected a ballot measure that would have added a $1 tax to a pack of cigarettes in the state's primary election Tuesday, an outcome observers attributed to a $47 million ad blitz by the tobacco industry.
6/4/2012 06:03 pm
(Bloomberg) June 4, 2012 - GE Healthcare today announced results of a unique partnership with Fred Hutchinson Cancer Research Center and the Center for Sustainable Health at Arizona State University. This partnership is directed at identifying areas in oncology where diagnostics could provide high value through reducing costs, while at the same time maintaining or improving patient outcomes.
6/4/2012 05:05 pm
(Yahoo! Finance) June 4, 2012 - Jennerex highlights phase 2b liver cancer trial as well as programs in colorectal cancer and multi-dose IV administration.
6/4/2012 05:04 pm
(ASCO) June 4, 2012 - New studies highlighting findings that will lead to improvements in the patient experience and identifying potential risks for development of cancers in the future were released today at a press briefing at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO).
6/4/2012 05:04 pm
(ASCO) June 4, 2012 - New studies highlighting the promise of individualized, precision medicine were released today at a press briefing at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO).
6/2/2012 05:05 pm
(San Jose Mercury News/Associated Press) June 1, 2012 - Fabled as a mecca for the health-conscious and fitness-obsessed, California is also one of only a few states that has not hiked its cigarette taxes in the last decade, meaning it is less expensive to light up in Los Angeles and San Francisco than in many other places in the country.
6/2/2012 05:03 pm
(NASDAQ) June 1, 2012 - Results highlight sapacitabine's activity in MDS and potential role as second-line therapy after treatment failure of hypomethylating agents.
5/10/2012 12:01 pm
(Kaiser Health News) May 9, 2012 - The government has identified hundreds of hospitals whose Medicare patients are incurring especially high bills, a first step toward using bonuses and penalties to encourage more efficient care.
5/10/2012 11:04 am
(ESTRO) May 10, 2012 - New findings from a large Danish database of cancer patients suggest that, even though the human papilloma virus (HPV) can trigger throat cancer, patients who are HPV-positive and are light smokers, or don’t smoke at all, have a good response to treatment using radiotherapy alone, without the addition of chemotherapy with its consequent toxic side-effects.
5/7/2012 12:00 pm
(Kaiser Health News) May 7, 2012 - Implementation of this provision of the health law, which is designed to shed light on the financial arrangements between doctors, drug makers and medical device companies, will now begin in 2013.
5/3/2012 12:00 pm
(ESMO) May 3, 2012 - New findings presented at Europe’s leading breast cancer translational research conference this year shed new light on the many biological differences between individual breast cancers.
4/27/2012 11:04 am
(Vanderbilt-Ingram Cancer Center) Apr 26, 2012 - The future of omics and personalized cancer medicine was in the spotlight as Vanderbilt University School of Medicine hosted a regional meeting of the Institute of Medicine (IOM) of the National Academies.
3/28/2011 12:05 pm
(Karolinska Institutet) Mar 24, 2011 - Simulated acupuncture - sometimes referred to as placebo - is just as beneficial as real acupuncture for treating nausea in cancer patients undergoing radiotherapy, according to a study from Karolinska Institutet and Linköping University in Sweden.
3/25/2011 12:03 pm
(Wall Street Journal) Mar 25, 2011 - The Swiss family that has controlled drug giant Roche Holding AG for decades said one family member has dropped out of the group's voting pool, meaning that the family pool has lost majority voting control of the company.
3/22/2011 12:05 pm
(OSUCCC-James) Mar 22, 2011 - A novel psychological treatment for depressed patients coping with the stresses of cancer significantly improved their depressive symptoms, while also improving fatigue and mental health quality of life.
3/22/2011 12:05 pm
(UC San Diego) Mar 21, 2011 - During a radical surgery to treat a rare bone cancer, surgeons at UC San Diego Health System and Moores Cancer Center removed 50 percent of a patient’s pelvis.
3/22/2011 12:05 pm
(Seattle Genetics) Mar 22, 2011 - Seattle Genetics, Inc. today announced that it has entered into a collaboration agreement with Abbott under which Abbott will pay an upfront fee of $8 million for rights to utilize Seattle Genetics' antibody-drug conjugate (ADC) technology with antibodies to a single oncology target.
3/18/2011 11:05 am
(IB Times) Mar 18, 2011 - Quest Diagnostics Inc. announced an agreement to acquire smaller rival Celera Corp., a maker of diagnostic tests, for $8 per share to gain immediate access to genetic tests and pipeline of biomarkers.
3/17/2011 01:00 pm
(Wall Street Journal) Mar 17, 2011 - John F. Cogan, R. Glenn Hubbard and Daniel Kessler have it completely wrong on the "cost shifting" of health care from the uninsured to the insured ("ObamaCare and the Truth About 'Cost Shifting'," op-ed, March 11). It is not the insured who pay a price for the uninsured, it is the opposite.
3/3/2011 11:05 am
(Georgia Tech) Mar 2, 2011 - Manipulation of cells by a new microfluidic device may help clinicians improve a promising cancer therapy that harnesses the body’s own immune cells to fight such diseases as metastatic melanoma, non-Hodgkin’s lymphoma, chronic lymphocytic leukemia and neuroblastoma.
2/28/2011 12:00 am
(Los Angeles Times) Feb 27, 2011 - Seven-time Tour de France winner Lance Armstrong will launch a campaign in support of the California Cancer Research Act, which would add a $1 tax to tobacco products.
2/23/2011 12:00 am
(Washington Post) Feb 22, 2011 - Are cellphones safe? That question has gotten a lot of attention, but so far there has been no convincing evidence that those ubiquitous devices cause health problems. A new federal study may stir things up further, but the bottom line again is that the study raises more questions than it answers.
2/22/2011 12:00 am
(Frisco Texas News) Feb 20, 2011 - According to new findings, abiraterone acetate, an investigational drug, can prolong survival of men with metastatic castration-resistant prostate cancer (CRPC) whose disease is progressing after receiving docetaxel-based chemotherapy.
2/15/2011 12:00 am
(Washington Post) Feb 15, 0211 - Eat more fiber and you just may live longer. That's the message from the largest study of its kind to find a link between high-fiber diets and lower risks of death not only from heart disease, but from infectious and respiratory illnesses as well.